)
Asahi Kasei (3407) investor relations material
Asahi Kasei Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 2026 saw significant growth in net sales, operating income, and net income, driven by strong performance in Pharmaceuticals, Critical Care, and Electronics, and the nonrecurrence of prior-year losses in Material.
Net sales for Q1 2026 rose 11.9% year-over-year to ¥826,157 million, with operating income up 51.5% and net income attributable to owners of the parent surging 172.7% to ¥53,766 million.
Comprehensive income improved significantly to ¥78,774 million from a loss of ¥7,386 million in Q1 2025.
Strategic capital allocation and business portfolio transformation continued, including major M&A (Aicuris acquisition) and divestitures in non-core or low-performing businesses.
Financial highlights
Q1 2026 net sales: ¥826.2 billion (+11.9% YoY); operating income: ¥81.3 billion (+51.5% YoY); net income: ¥53.8 billion (+172.7% YoY).
EBITDA increased 32.6% to ¥133.9 billion; operating margin improved to 9.8%.
Gross profit increased to ¥290,352 million from ¥240,498 million year-over-year, while operating income reached ¥81,305 million, up from ¥53,653 million.
Ordinary income jumped 70.8% to ¥85,330 million, and net income per share rose to ¥39.73 from ¥14.52.
H1 2026 forecast: net sales ¥1,686.0 billion (+13.4% YoY), operating income ¥145.0 billion (+34.9% YoY), net income ¥89.0 billion (+34.3% YoY).
Outlook and guidance
Fiscal 2026 net sales are forecast at ¥3,254,000 million (+5.8% year-over-year), with operating income of ¥248,000 million (+7.3%) and net income attributable to owners of the parent at ¥160,000 million (+0.8%).
Both operating and net income are expected to rise in H1 2026, with continued strong performance in First Priority businesses.
Interim and annual dividend forecasts are ¥22.00 and ¥44.00 per share, respectively.
Share repurchase program of up to ¥40 billion is underway.
- On track for ¥270 billion operating income in FY2027, driven by Healthcare and Electronics growth.3407
Corporate presentation - Record earnings growth driven by Pharmaceuticals, Electronics, and Healthcare, with strong FY 2026 outlook.3407
Q4 2026 - FY2027 operating income target of ¥270 billion is within reach, led by Healthcare and AI/semiconductors.3407
Investor presentation - Aicuris acquisition secures a robust infectious disease pipeline, accelerating pharma growth.3407
Acquisition presentation - Record operating income and net income growth, with an upwardly revised full-year forecast.3407
Q3 2026 - Net income up 10% YoY, full-year profit guidance raised, and dividend maintained.3407
Q2 2026 - Operating income rose but net income plunged on one-time and extraordinary losses; outlook and dividends improved.3407
Q1 2026 - Operating and net income surged, but currency losses drove comprehensive income negative.3407
Q2 2025 - Operating income jumped 128.9% YoY in Q1, with a strong outlook for FY2024.3407
Q1 2025
Next Asahi Kasei earnings date
Next Asahi Kasei earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)